EQS-DD: Newron Pharmaceuticals S.p.A.: Dr. Ulrich Köstlin, buy
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
26.06.2024 / 13:13 CET/CEST
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities / person
closely associated
a) Name
Title: Dr.
First name: Ulrich
Last name(s): Köstlin
2. Reason for the notification
a) Position / status
Position: Member of the administrative or supervisory body
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name
Newron Pharmaceuticals S.p.A.
b) LEI
8156002F8C11F80A9740
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument,
identification code
Type: Share
ISIN: IT0004147952
b) Nature of the transaction
Acquisition
c) Price(s) and volume(s)
Price(s) Volume(s)
10.20 EUR 14555.4 EUR
d) Aggregated information
Price Aggregated volume
10.2000 EUR 14555.4000 EUR
e) Date of the transaction
25/06/2024; UTC+2
f) Place of the transaction
Name: Xetra
MIC: XETR
---------------------------------------------------------------------------
26.06.2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
---------------------------------------------------------------------------
Language: English
Company: Newron Pharmaceuticals S.p.A.
via Antonio Meucci 3
20091 Bresso
Italy
Internet: www.newron.com
End of News EQS News Service
---------------------------------------------------------------------------
92693 26.06.2024 CET/CEST